Welcome to our dedicated page for Gabelli Health & Wellness news (Ticker: GRX), a resource for investors and traders seeking the latest updates and insights on Gabelli Health & Wellness stock.
The Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) is a diversified, closed-end management investment company with a primary objective of long-term capital growth. News about GRX often centers on its capital structure, distribution policy, and activities within the healthcare and wellness investment universe.
Investors following GRX news can expect regular announcements from the Board of Trustees regarding quarterly cash distributions to common shareholders, as well as any adjusting distributions made to satisfy regulated investment company requirements. These updates typically explain how distributions relate to income, realized capital gains, and potential return of capital, along with preliminary estimates of the tax character of payments.
Another recurring news theme for the Fund is its use of cumulative preferred shares. Company releases have detailed offerings and private placements of preferred share series, including terms such as dividend rates, liquidation preferences, non-call periods, and mandatory redemption dates. News has also covered redemptions of outstanding preferred series and the Fund’s plans for using proceeds from new preferred issuances.
Coverage of GRX may also include information about changes or additions to the investment team, particularly portfolio managers and analysts focused on healthcare-related sectors. These items provide context on how the Fund is managed within Gabelli Funds, LLC.
For investors and researchers, the GRX news page brings together these distribution announcements, preferred share actions, and management updates in one place. Reviewing this news history can help users understand how the Fund’s policies, capital structure, and thematic focus in healthcare and wellness have been communicated over time.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) declared a $0.17 per share cash distribution payable on December 19, 2025 to shareholders of record on December 12, 2025. The Board sets quarterly distributions and may add an adjusting December distribution to meet RIC tax requirements.
The Fund estimates 2025 distributions will be ~5% net investment income and ~95% net capital gains on a book basis; final tax components will be determined after year end and reported on Form 1099-DIV in early 2026.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has declared a quarterly cash distribution of $0.17 per share, payable on September 23, 2025, to shareholders of record as of September 16, 2025. The Fund reaffirms its annualized distribution of $0.68 per share.
The current distribution composition includes approximately 6% from net investment income, 74% from net capital gains, and 20% return of capital. The Board of Trustees reviews the distribution amount quarterly, considering the Fund's net asset value and market conditions. The distribution policy may be modified or terminated at any time.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has declared a quarterly cash distribution of $0.15 per share, payable on March 24, 2025, to shareholders of record on March 17, 2025. The current distribution breakdown consists of approximately 1% from net investment income, 4% from net capital gains, and 95% return of capital on a book basis.
The Fund's Board of Trustees reviews potential distributions quarterly, considering net asset value and market conditions. The distribution policy may be modified or terminated at any time. Distributions can be treated as long-term capital gain or qualified dividend income, subject to a maximum 20% federal tax rate for individuals in taxable accounts. U.S. shareholders meeting certain income thresholds will be required to pay an additional 3.8% Medicare surcharge on their net investment income.
Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) has declared a quarterly cash distribution of $0.15 per share, payable on December 20, 2024, to shareholders of record on December 13, 2024. The distribution composition is approximately 5% from net investment income, 84% from net capital gains, and 11% return of capital. The Board of Trustees reviews potential distributions quarterly, considering the Fund's net asset value and market conditions. The distribution policy may be modified or terminated at any time, and distributions might be subject to various tax treatments including long-term capital gains and qualified dividend income.
The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has declared a $0.15 per share cash distribution for the third quarter, payable on September 23, 2024 to shareholders of record on September 16, 2024. The Fund aims to pay quarterly distributions, with the amount determined by the Board of Trustees. Additionally, an adjusting distribution may be paid in December to meet minimum distribution requirements.
The distribution breakdown for 2024 is estimated as 5% from net investment income, 88% from net capital gains, and 7% deemed return of capital. However, this is subject to final determination after year-end. Shareholders will receive detailed tax information via Form 1099-DIV in early 2025. The Fund's distribution policy is subject to modification by the Board of Trustees, considering factors such as net asset value and market conditions.
The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) announced a $0.15 per share distribution for Q2 2024, payable on June 21, 2024, to shareholders recorded by June 13, 2024.
The Fund aims for quarterly distributions, with potential adjusting distributions in December based on income and net capital gains.
Distributions may be classified as long-term capital gain, qualified dividend income, or return of capital. Currently, the 2024 distributions are estimated to consist of 3% net investment income, 27% net capital gains, and 70% return of capital.
The Board of Trustees reviews and may adjust the distribution policy based on the Fund’s net asset value and market conditions.
Final tax treatment of distributions will be detailed to shareholders through Form 1099-DIV in early 2025.
Summary not available.
Summary not available.
Summary not available.